Genetic polymorphism of CYP3A4 associated with reduced response to statin therapy in Pakistani cardiac and dyslipidemic patients: A cross-sectional observational study.

Rafay Rawaal H, Arif A, Jamal A, Ur-Rehman K

Open source

DOI
10.36721/pjps.2026.39.8.220.1
Published
2026 Aug
Container
Pakistan journal of pharmaceutical sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps.2026.39.8.220.1,
  title = {Genetic polymorphism of CYP3A4 associated with reduced response to statin therapy in Pakistani cardiac and dyslipidemic patients: A cross-sectional observational study.},
  author = {Rafay Rawaal H and Arif A and Jamal A and Ur-Rehman K},
  year = {2026},
  journal = {Pakistan journal of pharmaceutical sciences},
  doi = {10.36721/pjps.2026.39.8.220.1},
  url = {https://doi.org/10.36721/pjps.2026.39.8.220.1}
}

RIS

TY  - JOUR
TI  - Genetic polymorphism of CYP3A4 associated with reduced response to statin therapy in Pakistani cardiac and dyslipidemic patients: A cross-sectional observational study.
AU  - Rafay Rawaal H
AU  - Arif A
AU  - Jamal A
AU  - Ur-Rehman K
PY  - 2026
JO  - Pakistan journal of pharmaceutical sciences
DO  - 10.36721/pjps.2026.39.8.220.1
UR  - https://doi.org/10.36721/pjps.2026.39.8.220.1
ER  - 

APA

H, R. R., A, A., A, J., & K, U. (2026). Genetic polymorphism of CYP3A4 associated with reduced response to statin therapy in Pakistani cardiac and dyslipidemic patients: A cross-sectional observational study.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps.2026.39.8.220.1

Source records